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Abstract  
Objectives: Chronic pain may increase the risk of cardiac disease, but the extent to 
which confounding variables account for this association has yet to be satisfactorily 
established. This study aims to examine the possibility of an independent association 
between these two variables.  
Methods: We applied logistic regression analysis to data from 8596 adults surveyed in 
a population study of the health of the population of England. The association 
between cardiac disease (angina and/or myocardial infarction) and chronic pain (pain 
lasting greater than three months) was explored, taking account of 10 potentially 
confounding variables including the regular use of non-steroidal anti-inflammatory 
drugs.  
Results: Participants reporting chronic pain (n=3023) were more likely to experience 
cardiac disease than those without pain: odds ratio (OR) 1.55, 95% confidence 
interval (CI) 1.15-2.07. Subsets of participants fulfilling various criteria for high-
intensity chronic pain demonstrated stronger associations with cardiac disease 
suggesting a ‘dose-response’ element to the relationship: chronic widespread pain OR 
3.3 (95% CI 1.42-7.68); higher-disability chronic pain OR 2.35 (95% CI 1.71-3.23); 
higher average chronic pain score OR 1.95 (95% CI 1.40-2.71). Adjustment for 
regular prescription of non-steroidal anti-inflammatory drugs did not reduce the 
association of chronic pain with cardiac disease.  
Discussion: Patients reporting chronic pain, in particular those most severely affected, 
may be at significantly increased risk of cardiac disease. Future studies should focus 
on determining whether reducing the impact of chronic pain can improve cardiac 
health. 
Keywords: Chronic pain; cardiac disease; cardiovascular disease; angina; myocardial 
ischemic  
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Introduction 
A late 20
th
 Century study reporting that farmers with a history of back pain had an 
almost five-times greater risk of death from ischemic heart disease than those without 
pain raised interest in the possibility of an association between chronic pain and 
cardiovascular disease 
1
. A more recent study, using data from a large population 
survey in England, demonstrated a significantly higher prevalence of cardiac disease 
in adults (aged 65 and over) who also reported chronic pain 
2
. This study was limited 
by the use of surrogates for chronic pain, derived by combining a diagnosis of long-
term musculoskeletal conditions with self-reported moderate or severe pain on the day 
of the survey. While it may not be possible to establish the directionality of an 
association based on data from cross-sectional studies, there is additional evidence 
from longitudinal studies suggesting chronic pain as precursor of cardiovascular 
morbidity 
3-7
. Further support for a link between these variables comes from research 
focusing on pathogenesis. For example, atherosclerosis of the lumbar arteries has 
been shown to be the forbearer of lower back pain 
8
, whilst widespread chronic pain 
has been implicated in alterations of endothelial function 
9 10
, hypothalamo-pituitary 
axis 
11
 and autonomic nervous system functioning 
12-15
.  
Some authors have sought to validate a causal relationship between chronic pain and 
cardiovascular disease by demonstrating a dose-response effect.  In 2000, Cote and 
colleagues reported that the presence of high-grade chronic neck pain, defined 
according to ‘Grading the Severity of Chronic Pain’ questionnaire, was more likely to 
be associated with cardiovascular conditions moderately or severely impacting health 
than either intermediate grade chronic pain or low grade chronic pain 
16
.  Other 
authors have shown that the number of pain sites may be relevant to the degree of 
cardiovascular morbidity by comparing outcomes amongst cohorts of patients 
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reporting chronic widespread pain (>4 body areas, including axis, upper and lower 
body), with those reporting only chronic regional pain 
17 18
. Claims that the risk of 
cardiovascular disease is proportional to the duration, severity or distribution of 
chronic pain need to be balanced against the understanding that these studies were 
entirely based on observational data, with little consistency in the terminology used to 
define pain symptoms and/or cardiovascular indices. The ability to establish causality 
has also been hampered by the failure to comprehensively address potentially 
confounding variables, in particular the regular use of non-steroidal anti-inflammatory 
drugs (NSAIDS) that have well-publicized effects on cardiovascular health 
19
.  
In this study we have used national data, collected as part of the Health Survey for 
England (HSE) to explore the hypothesis that chronic pain is independently associated 
with cardiac disease and that this augmented risk is proportional to the intensity of 
pain symptoms. 
Methods 
Study design: The Health Survey for England is an annual survey collecting 
information on various aspects of physical health, lifestyle behaviors, social care and 
mental health from a representative sample of the population of England 
20
. The 
survey was first instructed in 1991, and the 21
st
 chapter (collected in 2011) is the first 
to include data specifically about chronic pain symptoms. These data are gathered 
through interviews with respondents, randomly selected from post-code allocated 
sampling units across the country; objective measures of health such as height, weight 
and blood pressure are then recorded alongside pre-specified demographics relating to 
health and social care. Ethical approval for the 2011 survey was obtained from the 
Oxford A Research Ethics Committee (reference number 10/H0604/56). 
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Study Population: Participants were approached at 8992 private households, selected 
through a process of stratified sampling from 562 geographical sampling units, in 
order to achieve a nationally representative sample of the English population. A total 
of 10,617 (8,610 adults) participants were interviewed, achieving a household 
response rate of 66%. From this cohort 5,715 participants also had a nurse visit 
allowing further questioning, collection of various anthropomorphic measurements 
and, where appropriate, blood and salivary samples. Quality control methods to 
minimize bias in data collection included recall and review of data from both 
interviews and nurse visits, in approximately 10% of productive households. 
Dependent variables: Participants were considered to have cardiac disease if they 
responded ‘Yes’ to either of the following questions: (i) “Were you told by a doctor 
that you had Angina?” (ii) “Were you told by a doctor that you had a Heart Attack 
(including myocardial infarction or coronary thrombosis)?” 
A supplementary variable (“cardiac last year”) was generated from responses to the 
same questions, which restricted the outcome to cardiac diagnoses given by a doctor 
in the year leading up to the survey (albeit not necessarily given for the first time in 
this preceding year). 
Independent variables: Participants were considered to fulfill the criteria for chronic 
pain if they responded “Yes” to both of the following questions: (i) “Are you 
currently troubled by pain or discomfort, either all the time or on and off?” (ii) “Have 
you had this pain or discomfort for more than 3 months?” 
Pain disability grade was assessed at interviews using responses to the ‘Grading the 
severity of Chronic Pain Scale’ (GSCP), a validated bi-dimensional measure of 
chronic pain severity, integrating pain intensity with pain-specific disability 
21 22
. For 
the purposes of the statistical analysis grades III and IV were collectively used to 
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represent higher-disability chronic pain, while grades I and II were grouped to 
represent lower-disability chronic pain, as has been done previously in studies 
addressing cardiovascular outcomes in chronic pain patients 
16 23
. Pain score severity 
was taken as an average of participants’ current pain score (ranging from 0-10), worst 
pain score in previous six-months and average pain score in the previous six months. 
A mean score of 5 or above represented ‘higher average chronic pain score’ 21. Pain 
distribution was classified according to the number of body sites in which chronic 
pain was reported; participants were offered up to seven body locations including 
back, neck/shoulder, head/face/dental, stomach/abdominal, limbs, chest or ‘other’. 
Participants reporting chronic pain in four or more distinct body areas were 
considered to have ‘chronic widespread pain’ although we acknowledge this 
definition is not strictly adherent to the American College of Rheumatologists 
standard 
24
. In order to prevent bias from Angina being categorized as chronic pain in 
the chest area, data from all participants reporting chronic pain in the chest area were 
excluded from the statistical analysis. 
Confounding variables: Age, gender and Income were obtained directly from the 
core survey questions. The latter was used as a measure of social class, calculated by 
applying a McClement score to each household (integrating number, age and 
relationships of adults and children in household) and dividing the total household 
income by this score. Subjects were grouped into the following quintiles: <£11,676.65, 
£11,676.66-£19,117.65, £19,117.66-£27,704.92, £27,704.93-£47,794.11, and 
>£47,794.12. The effect of smoking was accounted for by dividing subjects into one 
of three groups; a) never-regular smokers, b) ex-regular smokers or c) current 
smokers. Body mass index was derived from validated height and weight 
measurements and participants were separated into quintiles: <18.5, 18.5-24.9, 25-
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29.9, 30-39.9 and >40. Participants were classified as hypertensive or diabetic if they 
reported ever receiving these diagnoses directly from a physician. Anxiety and 
depression were gauged as part of the general health questionnaire with subjects self-
reporting as ‘not anxious or depressed’, ‘moderately anxious or depressed’ or 
‘extremely anxious or depressed’. Regular use of NSAIDS was included if the 
participant had a regular prescription for any drug coded under section 10.01.01 in the 
British National Formulary, allowing us to differentiate between NSAIDS taken for 
analgesic purposes and those taken for cardiovascular disease (e.g. Aspirin).    
Statistical analysis: All data was processed using STATA SE (version 13). Serial 
logistic regression analyses were performed addressing the association between 
cardiac disease and chronic pain, chronic pain distribution, chronic pain disability, 
and average chronic pain score. The process was then repeated using ‘cardiac last 
year’ as the dependent variable. The regression initially included the full complement 
of confounding variables; non-significant variables were subsequently removed in a 
step-wise fashion in order to generate our final models. Removing non-significant 
confounding variables allowed for a greater sample size to be included into the final 
analyses, since there was missing data for some variables. To this effect BMI and 
regular NSAIDS were removed from all regression models, anxiety and depression 
were removed from models analyzing cardiac disease by chronic pain distribution and 
by chronic pain disability, smoking was removed from all models using cardiac 
disease in the last year as the dependent variable, and diabetes from the regression 
model analyzing cardiac disease in the last year against chronic pain disability.  
Results 
The characteristics of the study population are presented in Table 1 and Table 2. In 
total 8610 adults participated in the survey; completed data for question on cardiac 
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disease and chronic pain prevalence were available from 8596 participants (male = 
3815, female = 4781). The median age of survey respondents with completed data 
was 49 years. 
The prevalence of cardiac disease was 5.5% (n=471).  Just over a third of those with 
cardiac disease (n=164) were diagnosed in the year leading up to the survey. In both 
instances male participants reported cardiac disease more frequently than did female 
participants. Over 35% of respondents (n=3023) reported chronic pain symptoms; 
chronic pain symptoms were more common in female participants than in male 
participants (38% vs. 33%).   
Cardiac disease (angina or myocardial infarction) occurred more frequently amongst 
participants reporting chronic pain, with an odds ratio (OR) of 1.87 (95% confidence 
intervals [CI] 1.51-2.34), after adjusting for the non-modifiable risk factors age and 
gender. Table 3 shows the results of a logistic regression analysis in which the 
association between chronic pain and cardiac disease was tested alongside the full 
complement of modifiable and non-modifiable confounding variables.  Body mass 
index and NSAIDS were not independently associated with cardiac disease and were 
removed from the final model. In fact, the estimated OR for cardiac disease amongst 
users of NSAIDS was always 1.00 or less than 1.00 in all models of risk factors for 
cardiac disease including chronic pain or chronic pain by severity and other 
confounding variables. The use of NSAIDS was therefore not adjusted for in the 
results shown in Table 4 and Table 5, which report OR and CI adjusted for only the 
statistically significant confounding factors.  They show that those with chronic pain 
are more likely to report cardiac disease, with OR 1.55 (95% CI 1.15-2.07).  The odds 
of cardiac disease in the presence of chronic pain was much higher when cardiac 
disease was restricted to the final year of the study, OR 3.20 (95% CI 1.65-6.18), with 
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a very similar result, OR 2.87 (95%CI 1.45-5.67) when adjusting for all potential 
confounding variables.   
A sub-set (71 people) of those who had reported chronic pain experienced it in four or 
more distinct body areas (chronic widespread pain), approximating to 2.3% of the 
chronic pain cohort (Table 1).  There were significantly fewer male participants 
reporting chronic pain, who met our criteria for chronic widespread pain than females 
(1.2% vs. 3.1%).  Cardiac disease was significantly more common in participants 
reporting chronic regional pain (1-3 sites) and those reporting chronic widespread 
pain, when compared to participants with no chronic pain. However, the odds of 
cardiac disease was more than doubled in the chronic widespread pain group as 
compared to the chronic regional pain group OR 3.30 (95% CI 1.42-7.68) vs. OR 1.45 
(95% CI 1.12-1.89), respectively.  Similar proportions were evident in the “cardiac-
last-year” model (Table 5). 
Almost twice as many chronic pain sufferers were classified as having low-disability 
chronic pain (GSCP Grades I and II) than high-disability chronic pain (GSCP grades 
III and IV).  Only high-disability pain was statistically significantly associated with 
cardiac disease after correction for confounding variables OR 2.35 (95% CI 1.71 – 
3.23) and OR 6.70 (95% CI 3.26-13.75) for cardiac disease and cardiac disease in the 
last year, respectively. 
Just over half of the participants with chronic pain reported average chronic pain 
scores greater than or equal to 5/10.  Again, a statistically significant association with 
cardiac disease was only apparent in the cohort reporting higher average chronic pain 
scores.  The odds for this association were more than doubled when outcomes were 
restricted to the final year of the survey OR 4.13 (95% CI 2.05-8.33) vs. OR 1.95 
(95% CI 1.40-2.71). 
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Participants excluded from the statistical model accounting for the full complement of 
confounding variables were marginally older, wealthier, and more likely to be 
prescribed NSAIDS but less often hypertensive and diabetic then were included 
participants. With progressive removal on non-significant variables the proportion of 
‘excluded’ participants were reduced; consequently the study population more closely 
represented the survey population.  
Discussion 
The aim of our study was to explore the hypothesis that chronic pain may be 
independently associated with cardiac disease, and to qualify the strength of this 
association by searching for a dose-response relationship between the two variables. 
We have demonstrated that participants reporting chronic pain symptoms were 55% 
more likely to experience cardiac disease than those not reporting chronic pain, after 
adjustment for confounding variables.  In our study we used three different indices for 
pain intensity: chronic pain distribution, chronic pain disability and average chronic 
pain score. Our data indicate that cardiac risk increases markedly in-line with chronic 
pain intensity, irrespective of the measure used.  
Our results are consistent with published studies citing statistically significant 
increases in cardio-vascular morbidity, ranging from 18% to 83% 
25-27
, that are also 
most pronounced in populations with higher-intensity chronic pain 
17 18
. However, in 
previous studies confounding variables were not comprehensively accounted for in 
the statistical models used.  We have adjusted for a wide range of potentially 
confounding cardiovascular risk factors including: age, gender, socio-economic status, 
body mass index, diabetes, hypertension, smoking, anxiety, depression and regular 
use of non-steroidal anti-inflammatory drugs (NSAIDS).  To our knowledge this is 
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the first study to account for the use of these drugs as a confounding variable in the 
association between chronic pain and cardiovascular disease. 
We found that the regular use of NSAIDS was independently associated with both 
chronic pain and cardiac disease.  However, it was not a statistical confounder in the 
association between chronic pain and cardiac disease (Table 3). Interestingly, when 
logistic regression analysis was used to quantify the association between NSAIDS use 
and the presence of cardiac disease, adding chronic pain (as a potential confounder) to 
the model does in fact remove statistical significance (results not shown).  While it 
would be simplistic to surmise that the cardiac risk attributable to regular use of 
NSAIDS could be explained entirely by co-existing chronic pain, our data highlight 
the complex interplay between these three factors in clinical practice; reaffirming the 
need to carefully balance the overall cardiac risk against the potential analgesic 
benefit NSAIDS could provide in chronic pain patients.  
Strengths and limitations: Our study is based on observational data from a national 
survey. Self-reporting of chronic physical conditions has previously been shown to 
demonstrate moderate to high agreement with data from medical records 
28
, and we 
feel the large, nationally representative, sample size, as well as the quality control 
measures used by the Health Survey for England to validate the data, add robustness 
to our analysis. However, an important limitation of the present study is that anxiety 
and depression were not measured using well-validated assessments tools. Instead, 
participants were asked whether they feel depressed or anxious, moderately depressed 
or anxious, or severely depressed or anxious, and we cannot really know if 
participants were really having depressive symptoms or just showing some distress. 
There was also no specific assessment of post-traumatic stress disorder that has been 
linked with both chronic pain and cardiovascular disease 
29 30
, and would have ideally 
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been adjusted for as a confounding variable in the statistical analysis. In some 
instances the questioning format used in the survey was more restrictive than we 
would have liked, and the coding of prescription drugs did not allow us to identify the 
specific anti-depressant medicines or opioid analgesics used by participants, some of 
which may be associated with an increased risk of cardiovascular events 
31 32
. 
Furthermore, the data on medication usage were limited to prescription drugs, 
therefore we were not able to account for over-the-counter use of NSAIDS, nor could 
we identify the dose or quantity of the drugs actually taken by study participants.  
As the data source is cross-sectional, we are limited in our ability to attribute 
directionality. For example it is possible that in some instances cardiac disease 
preceded or perhaps even predisposed to chronic pain, as would be the case with 
chronic chest pain. In order to address this issue we have excluded participants who 
reported chronic pain symptoms in the chest area from our analysis. Additionally we 
ran parallel regression analyses, restricting the cardiovascular outcome to the last year 
of the survey. The demonstration that all our outcomes remained statistically 
significant was re-assuring. In fact in all instances the likelihood of cardiac disease 
actually increased in the restricted outcome set, with a greater than 7-fold increased 
risk in participants reporting chronic widespread pain than those without pain.  
Population estimates from the prevalence of chronic pain in the United Kingdom 
range from 35% to 51.3% 
33 34
, with up to 16.5% of the general population reporting 
chronic widespread pain 
33
. Similar figures have been quoted from studies looking at 
the prevalence of severe chronic pain in European countries 
35
. Extrapolation of the 
results of our study across these populations highlights a fairly underpublicized public 
health concern. While we are unable to establish causality in the absence of further 
support from longitudinal studies, we can acknowledge that chronic pain populations, 
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in particular those most severely affected, are likely to benefit from regular 
assessment of cardiac risk, and targeted measures to reduce this risk.  
In conclusion, this study has found an increased prevalence of cardiovascular disease 
amongst survey participants reporting chronic pain, an association that retains 
statistical significance even after corrections for potentially confounding 
cardiovascular risk factors. These results support the notion that chronic pain may be 
an independent and modifiable risk factor for cardiac disease, and aid in highlighting 
a hitherto underpublicized public health concern. Future work needs to address the 
possibility of modifying the impact of chronic pain on cardiovascular morbidity and 
mortality through improved pain control and reduction of symptom intensity. 
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TABLE 1: PARTICIPANT DEMOGRAPHICS BY PAIN STATUS AND SEVERITY 
 
Variable  "n" 
"n"=male 
(%) 
Age mean (SD) Age Range 
"n" with Cardiac 
(%) 
"n" with 
Cardiac last 
year§ (%) 
Total survey adults 8610 3822 (44) 49.64 (18.7) 16-100 471 (5.5) 164 (1.9) 
Cardiac disease       
     No 8136 3537 (43) 48 (18.3) 16-100 - - 
     Yes 471 283 (60) 70 (12.1) 27-96 - - 
     Yes (last year only)§ 164 97 (59) 70.1 (11.9) 31-94 - - 
Chronic pain       
     No 5397 2510 (46) 45.5 (18.3) 16-100 152 (2.8) 27 (0.5) 
     Yes 3023 1225  (41) 56.6 (17.2) 16-97 249 (8.2) 87 (2.9) 
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Pain distribution       
     Regional chronic pain 
(1-3 sites) 
2950 1208 (41) 56.6 (17.3) 16-97 238 (8) 81 (2.8) 
     Widespread chronic 
pain  (>3 sites) 
71 15 (21) 56.5 (16.6) 19-87 11 (15) 6 (8.7) 
Pain disability*       
     Low disability (grade I-
II)  
2081 863  (41) 55.1 (17.1) 16-97 122 (5.9) 38 (1.8) 
     High disability (grade 
III-IV)  
913 346 (37) 59.8 (17.0) 16-96 125 (13.7) 48 (5.3) 
Pain score severity       
     Low (average pain score 
1-4) 
1416 652 (46) 54.9 (17.4) 16-97 75 (5.3) 21 (1.5) 
     High (average pain 
score >4) 
1537 552 (35) 58 (17.0) 16-95 170 (10.8) 64 (4.1) 
 
n (number), SD (standard deviation) 
§A subgroup analysis was performed on subjects who were diagnosed with cardiac disease in the year leading up to the survey 
*Pain disability was derived from the 'Chronic pain grade scale' Questionnaire 
†Numbers in complementary categories may not add up to total number of patients because of missing data 
 
TABLE 2: DISTRIBUTION OF CONFOUNDING VARIABLES BY CHRONIC PAIN STATUS 
 
 Chronic Pain Status 
 
Cardiac Disease Status 
 Yes (n=3023) No (n=5397) Yes (n=471) No (n=8136) 
  n (%) n (%) n (%) n (%) 
Gender     
     Male 2510 (46) 1225 (41) 283 (60) 3537 (43) 
     Female 2887 (54) 1798 (59) 188 (40) 4599 (57) 
Income     
     >£47794.12 1011 (24) 407 (17) 77 (22) 1124 (17) 
     >£27704.92 <=£47794.12  953 (23) 442 (18) 115 (33) 1303 (20) 
     >£19117.65 <=£27704.92 798 (19) 525 (21) 89 (26) 1268 (20) 
     >£11676.65 <=£19117.65 798 (19) 577 (24) 38 (11) 1369 (21) 
     <=£11676.65 662 (16) 496 (20) 26 (8) 1402 (22) 
Age     
     16-29 1212 (22) 216 (7) 1 (0) 1444 (18) 
     30-39 1048 (19) 319 (11) 4 (1) 1379 (17) 
     40-49 1045 (19) 533 (18) 23 (5) 1580 (19) 
     50-59 735 (14) 555 (18) 55 (12) 1276 (16) 
     60-69 707 (13) 640 (21) 116 (25) 1267 (16) 
     70-79 434 (8) 454 (15) 159 (34) 766 (9) 
     >80 216 (4) 306 (10) 113 (24) 424 (5) 
Body Mass Index     
     <18.5 80 (2) 28 (1) 4 (1) 107 (2) 
     18.5-24.9 1728 (39) 673 (28) 64 (18) 2375 (36) 
      25-29.9 1692 (38) 930 (38) 136 (39) 2524 (38) 
     30-39.9 888 (20) 704 (29) 136 (39) 1505 (23) 
     >40 85 (2) 96 (4) 9 (3) 177 (3) 
Smoking history     
     Never regular 3015 (56) 1378 (46) 185 (39) 4286 (53) 
     Ex-regular 1260 (24) 1029 (34) 212 (45) 2139 (27) 
     Regular 1067 (20) 601 (20) 72 (15) 1635 (20) 
Raised blood pressure     
     Yes 1116 (21) 1149 (38) 167 (36) 6086 (75) 
     No 4278 (79) 1872 (62) 303 (64) 2044 (25) 
Diabetes Mellitus     
     Yes 5153 (95) 2728 (90) 345 (73) 7677 (95) 
     No 243 (5) 290 (10)  126 (27) 446 (5) 
Self-reported 
anxiety/depression 
  
  
     None 3815 (80) 1681 (62)  223 (59) 5336 (74) 
     Moderate 859 (18) 893 (5) 132 (35) 1691 (23) 
     Extreme 76 (2) 98 (4) 20 (5) 172 (2) 
NSAID prescription     
     Yes 46 (1) 204 (7) 452 (96) 7895 (97) 
     No 5351 (99) 2819 (93) 19 (4) 241 (3) 
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TABLE 3: CHRONIC PAIN AND CARDIAC DISEASE ADJUSTING FOR ALL CONFOUNDING VARIABLES 
 
 OR p-value 95% CI 
Chronic pain 1.45 0.02 1.06-2.00 
NSAID prescription 1.00 1.00 0.53-1.89 
Gender (female) 0.48 < 0.001 0.35-0.66 
Income    
     >£47794.12 1.00 - - 
     >£27704.92 <=£47794.12  1.23 0.51 0.66-2.29 
     >£19117.65 <=£27704.92 1.52 0.15 0.87-2.66 
     >£11676.65 <=£19117.65 1.74 0.05 1.00-3.03 
     <=£11676.65 1.76 0.06 0.98-3.17 
Age    
     16-29 1.00 - - 
     30-39 2.78 0.38 0.29-26.95 
     40-49 6.85 0.07 0.87-53.96 
     50-59 19.11 0.004 2.56-142.93 
     60-69 42.51 < 0.001 5.80-311.80 
     70-79 76.24 < 0.001 10.34-526.31 
     >80 92.50 < 0.001 12.19-701.61 
BMI    
     <18.5 1.00 - - 
     18.5-24.9 0.48 0.27 0.13-1.76 
      25-29.9 0.58 0.40 0.16-2.06 
     30-39.9 0.71 0.59 0.20-2.53 
     >40 0.56 0.45 0.12-2.56 
Smoking history    
     Never regular 1.00 - - 
     Ex-regular 1.13 0.47 0.81-1.59 
     Regular 1.62 0.03 1.05-2.52 
Raised blood pressure 1.77 < 0.001 1.28-2.43 
Diabetes Mellitus 1.76 0.01 1.17-2.63 
Self-reported anxiety/depression    
     None 1.00 - - 
     Moderate 1.28 0.16 0.91-1.79 
     Extreme 1.23 0.68 0.46-3.27 
 
OR (odds ratio), se (standard error), CI (confidence intervals), NSAIDS (non-steroidal anti-inflammatory drugs), BMI (body 
mass index), n (number of participants included in analysis) 
 
 
 
 
TABLE 4: CARDIAC DISEASE AGAINST PAIN STATUS/INTENSITY CORRECTING FOR STATISTICALLY 
SIGNIFICANT CONFOUNDERS ONLY 
 
  OR p-value 95% CI 
Chronic pain status    
     No chronic pain 1.00 - - 
     Chronic pain* 1.55 < 0.001 1.15-2.07 
Chronic pain distribution    
     No chronic pain 1.00 - - 
     Regional chronic pain (1-3 sites)† 1.45 0.01 1.12-1.89 
     Widespread chronic pain  (>3 sites)† 3.30 0.01 1.42-7.68 
Chronic pain disability    
     No chronic pain 1.00 - - 
     Low disability (grade I-II) ‡ 1.11 0.48 0.82-1.51 
     High disability (grade III-IV) ‡ 2.35 < 0.001 1.71-3.23 
Chronic pain score severity    
     No chronic pain 1.00 - - 
     Low (average pain score 1-4)§ 1.09 0.65 1.75-1.60 
     High (average pain score >4)§ 1.95 < 0.001 1.40-2.71 
 
OR (odds ratio), se (standard error), CI (confidence intervals) 
 
*adjusted for gender, income, age, smoking, blood pressure, diabetes, and self reported anxiety/depression 
†adjusted for gender, income, age, smoking, blood pressure and diabetes 
 ‡adjusted for gender, income, age, smoking, blood pressure and diabetes 
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TABLE 5: CARDIAC DISEASE RESTRICTED TO THE FINAL YEAR OF THE SURVEY AGAINST PAIN 
STATUS/INTENSITY CORRECTING FOR STATISTICALLY SIGNIFICANT CONFOUNDERS ONLY 
 
  OR p-value 95% CI 
Chronic pain status    
     No chronic pain 1.00 - - 
     Chronic pain* 3.20 0.001 1.65-6.18 
Chronic pain distribution    
     No chronic pain 1.00 - - 
     Regional chronic pain (1-3 sites)† 3.10 0.001 1.60-6.02 
     Widespread chronic pain  (>3 
sites)† 
7.11 0.003 1.92-26.32 
Chronic pain disability    
     No chronic pain 1.00 - - 
     Low disability (grade I-II) ‡ 1.93 0.08 0.92-4.08 
     High disability (grade III-IV) ‡ 6.70 < 0.001 3.26-13.75 
Chronic pain score severity    
     No chronic pain 1.00 - - 
     Low (average pain score 1-4)§ 2.05 0.08 0.92-4.56 
     High (average pain score >4)§ 4.13 < 0.001 2.05-8.33 
 
OR (odds ratio), se (standard error), CI (confidence intervals) 
 
* adjusted for gender, income, age, blood pressure, diabetes, and self reported anxiety/depression 
† adjusted for gender, income, age, blood pressure, diabetes, and self reported anxiety/depression 
‡ adjusted for gender, income, age, blood pressure, and self reported anxiety/depression 
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